CYTEK BIOSCIENCES, INC. Marketable Securities, Unrealized Gain (Loss)
CYTEK BIOSCIENCES, INC. (CTKB) reported Marketable Securities, Unrealized Gain (Loss) of -$147.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-06-30 was -$147.00K.
- CYTEK BIOSCIENCES, INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-03-31 was -$201.00K.
- CYTEK BIOSCIENCES, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-12-31 was $38.00K.
- CYTEK BIOSCIENCES, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was $118.00K, a 39.49% decline year-over-year.
- CYTEK BIOSCIENCES, INC. marketable securities, unrealized gain (loss) for fiscal 2025 was $58.00K, a 40.21% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. marketable securities, unrealized gain (loss) for fiscal 2024 was $97.00K.
- CYTEK BIOSCIENCES, INC. marketable securities, unrealized gain (loss) for fiscal 2023 was -$29.00K, a 270.59% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. marketable securities, unrealized gain (loss) for fiscal 2022 was $17.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$147.00K 10-Q · filed 2026-08-05 | -$348.00K 10-Q · filed 2026-08-05 | -$310.00K derived: sum of 3 quarters · filed 2026-08-05 | -$192.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$201.00K 10-Q · filed 2026-05-07 | -$163.00K derived: sum of 2 quarters · filed 2026-05-07 | -$45.00K derived: sum of 3 quarters · filed 2026-05-07 | -$78.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $156.00K derived: sum of 2 quarters · filed 2026-02-26 | $123.00K derived: sum of 3 quarters · filed 2026-08-05 | $58.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $118.00K 10-Q · filed 2025-11-05 | $85.00K derived: sum of 2 quarters · filed 2026-08-05 | $20.00K 10-Q · filed 2025-11-05 | -$27.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$33.00K 10-Q · filed 2026-08-05 | -$98.00K 10-Q · filed 2026-08-05 | -$145.00K derived: sum of 3 quarters · filed 2026-08-05 | $50.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$65.00K 10-Q · filed 2026-05-07 | -$112.00K derived: sum of 2 quarters · filed 2026-05-07 | $83.00K derived: sum of 3 quarters · filed 2026-05-07 | $67.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $148.00K derived: sum of 2 quarters · filed 2026-02-26 | $132.00K derived: sum of 3 quarters · filed 2026-02-26 | $97.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $195.00K 10-Q · filed 2025-11-05 | $179.00K derived: sum of 2 quarters · filed 2025-11-05 | $144.00K 10-Q · filed 2025-11-05 | $141.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$16.00K 10-Q · filed 2025-08-06 | -$51.00K 10-Q · filed 2025-08-06 | -$54.00K derived: sum of 3 quarters · filed 2026-02-26 | -$39.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$35.00K 10-Q · filed 2025-05-08 | -$38.00K derived: sum of 2 quarters · filed 2026-02-26 | -$23.00K derived: sum of 3 quarters · filed 2026-02-26 | -$215.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.00K derived: sum of 2 quarters · filed 2026-02-26 | -$180.00K derived: sum of 3 quarters · filed 2026-02-26 | -$29.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $15.00K 10-Q · filed 2024-11-07 | -$177.00K derived: sum of 2 quarters · filed 2024-11-07 | -$26.00K 10-Q · filed 2024-11-07 | -$8.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$192.00K 10-Q · filed 2024-08-06 | -$40.00K 10-Q · filed 2024-08-06 | -$23.00K derived: sum of 3 quarters · filed 2025-02-28 | -$23.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $152.00K 10-Q · filed 2024-05-08 | $169.00K derived: sum of 2 quarters · filed 2025-02-28 | $169.00K derived: sum of 3 quarters · filed 2025-02-28 | $169.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $17.00K derived: sum of 2 quarters · filed 2025-02-28 | $17.00K derived: sum of 3 quarters · filed 2025-02-28 | $17.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-13 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |